Northwestern Mutual Wealth Management CO 89bio, Inc. Transaction History
Northwestern Mutual Wealth Management CO
- $118 Billion
- Q4 2024
A detailed history of Northwestern Mutual Wealth Management CO transactions in 89bio, Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 8,200 shares of ETNB stock, worth $78,802. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,200
Previous 8,200
-0.0%
Holding current value
$78,802
Previous $60,000
3.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ETNB
# of Institutions
173Shares Held
125MCall Options Held
78.7KPut Options Held
979K-
Janus Henderson Group PLC London, X016.5MShares$159 Million0.07% of portfolio
-
Ra Capital Management, L.P. Boston, MA14.2MShares$136 Million1.76% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.2MShares$98 Million3.26% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$71.9 Million0.94% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$67.4 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $447M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...